Taiwan FDA registration 50c3ab270416ad037a08704bbf31c962
ILIA IGG/IGM/igA negative quality solution solution
TW: 宜立亞IgG/IgM/IgA陰性品管液
Taiwan·Risk Class 2·PHADIA AB·Registered Mar 18, 2015 – Mar 18, 2030ActiveRegistration details
- Analysis ID
- 50c3ab270416ad037a08704bbf31c962
- Customs Code
- DHA05602717904
Company information
- Manufacturer
- PHADIA AB
- Manufacturer Country
- Sweden
- Authorized Representative
- PHADIA TAIWAN INC.
Product details
- Intended Use
- This product is used to monitor the performance of the Fadia 100, Fadia 200 and Fadia 250 instruments for in vitro determination of autologous antibodies.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- import
Dates and status
- Registration Date
- Mar 18, 2015
- Expiry Date
- Mar 18, 2030
About this record
Access comprehensive regulatory information for ILIA IGG/IGM/igA negative quality solution solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 50c3ab270416ad037a08704bbf31c962 and manufactured by PHADIA AB. The authorized representative in Taiwan is PHADIA TAIWAN INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices